Novel Cholesterol Drug Vupanorsen Shows Promising Effect But With Notable Safety Concerns MD Bureau7 April 2022 10:15 AM ISTGenetic loss-of-function variants in Angiopoietin-like 3 (ANGPTL3) are associated with lower levels of plasma lipids. A recent study suggests that...
Experimental siRNA Therapy Cuts Lipoprotein (A) by 98%: JAMA MD Bureau7 April 2022 9:30 AM ISTLipoprotein(a) (Lp[a]) has long been recognized as a genetically determined, independent risk factor for atherothrombotic cardiovascular disease. A...
FDA approves AVEIR VR leadless pacemaker system to treat patients with slow heart rhythms MD Editorial Team7 April 2022 9:00 AM ISTAbbott's Aveir single chamber (VR) pacing system is the world's only leadless pacemaker with a unique mapping capability to assess correct positioning...
Good hydration may reduce long-term risks for heart failure Dr. Kamal Kant Kohli7 April 2022 9:00 AM ISTStaying well-hydrated may be associated with a reduced risk for developing heart failure, according to researchers at the National Institutes of...
Higher fibre intake tied with reduced inflammation and CVD risk in older adults: Study Dr. Shravani Dali7 April 2022 9:00 AM ISTHigher fibre intake is tied with reduced inflammation and CVD risk in older adults, according to a recent study published in the JAMA Network Open. ...
NaF-PET/CT promising marker for disease severity and future risk in acute aortic syndrome patients: Study Medha Baranwal7 April 2022 9:00 AM ISTUK: PET-CT with F-18 sodium fluoride (NaF) is a promising noninvasive marker of disease severity and future risk in patients with acute aortic...
Tailored Electronic Health Record Improves Optimal Care For HF Patients: PROMPT-HF Trial MD Bureau7 April 2022 6:00 AM ISTHeart failure with reduced ejection fraction (HFrEF) is one of the most common chronic illnesses in the United States and carries a significant risk...
Omecamtiv mecarbil has Little Impact on Exercise Tolerance in HF patients: METEORIC-HF Trial Dr. Kamal Kant Kohli7 April 2022 6:00 AM ISTDURHAM, N.C.- Heart failure patients taking the investigational drug omecamtiv mecarbil experience little impact on their ability to exercise compared...
Second-generation Chocolate Touch device superior to first-generation DCB for blocked arteries in leg Dr. Kamal Kant Kohli7 April 2022 6:00 AM ISTAmong patients treated for a blocked artery in the leg, second-generation paclitaxel drug-coated balloon (DCB) led to better target vessel patency and...
Diltiazem may not improve coronary vasomotor dysfunction in angina and ANOCA- EDIT CMD Trial MD Editorial Team6 April 2022 10:00 AM ISTCardiac diseases are becoming very difficult to manage. Diltiazem is recommended and frequently prescribed in patients with angina and non obstructive...
PVCs and echocardiographic abnormalities during recovery associated with increased cV mortality MD Editorial Team6 April 2022 9:00 AM ISTExercise-induced premature ventricular contractions (PVCs) are common findings in exercise stress testing and have been described to associate with...
Symptoms of ASCVD strongly associated with MI risk in CKD patients Medical Dialogues Editorial Team6 April 2022 9:00 AM ISTSymptoms of atherosclerotic cardiovascular disease were substantially related with a greater risk of future myocardial infarction in patients with...
